you definitely heard NC correctly. He also mentioned that there were 50 enrolled out of 70 openings. Perhaps the new, improved formula could be used for further enrollments?
potsy great point...NC said there are currently two phase II myeloma trials, Mayo and Dana Farber. He also said there would be an update on FDA/ new formulation in the not to distant future. Someone asked if the new formulation is still taken orally. NC said 3 goals were met 1. increased bio availability. 2. no toxicity 3.taken orally